2003
DOI: 10.1016/s0169-5002(03)00152-1
|View full text |Cite
|
Sign up to set email alerts
|

The role of radiotherapy in treatment of stage I non-small cell lung cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

5
167
0
3

Year Published

2004
2004
2020
2020

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 279 publications
(175 citation statements)
references
References 23 publications
5
167
0
3
Order By: Relevance
“…In the present retrospective study of medically inoperable stage I NSCLC analysis of local control as assessed during the follow-up time (median 33 month), showed that only 12% of the tumours failed locally, a figure similar to other SBRT studies on this group of patients [22,28 Á35]. In a recent review of 18 papers published 1988 Á2000, reporting results with conventional RT, the incidence of local failure of stage I tumours was 40% (6.4 Á70%) [10]. Local failure has been reported up to at least 3 years after RT treatment of stage I NSCLC [29,36,37].…”
Section: Discussionsupporting
confidence: 70%
See 1 more Smart Citation
“…In the present retrospective study of medically inoperable stage I NSCLC analysis of local control as assessed during the follow-up time (median 33 month), showed that only 12% of the tumours failed locally, a figure similar to other SBRT studies on this group of patients [22,28 Á35]. In a recent review of 18 papers published 1988 Á2000, reporting results with conventional RT, the incidence of local failure of stage I tumours was 40% (6.4 Á70%) [10]. Local failure has been reported up to at least 3 years after RT treatment of stage I NSCLC [29,36,37].…”
Section: Discussionsupporting
confidence: 70%
“…The alternative treatment for these patients has been conventional fractionated external radiotherapy (RT) [6 Á9] with local control rates of 40 Á70% and 5-year survival rates of 5 Á30% [10Á13]. The most common site of relapse of early stage NSCLC treated with conventional RT is local failure [10]. Several studies report that large tumour size and insufficient dose of radiation are the main reasons for poor local control [7,9,10,12,14 Á17].…”
mentioning
confidence: 99%
“…2 The treatment of lung cancer with radiotherapy is technically challenging and local tumor control with standard radiation doses and techniques is often difficult to achieve. 3 Given that local recurrence is a leading cause of death in this patient population, techniques for improving local control may have an impact on survival rates.…”
Section: Introductionmentioning
confidence: 99%
“…Results showed that with IMRT there was a 10% reduction in the predicted rate of radiation pneumonitis and an overall decrease in the MLD of >2 Gy. 12 Christian et al, in a study of 10 patients with NSCLC, retrospectively compared 5 different IMRT plans using different fields (3,5,7, and 9 coplanar field and a 6 noncoplanar field ) to a six-field noncoplanar 3D-CRT plan for each patient. They found that using IMRT reduced the V 20 when more than 3 fields were used as compared to the 3D-CRT plan.…”
Section: Introductionmentioning
confidence: 99%
“…However, 33% of patients present with co‐morbidities that make them unfit for surgery 2. For these patients, local failure following conventionally fractionated external beam radiation therapy is in the order of 40% and treatment involves 20–30 attendances over 4–6 weeks 3. Stereotactic ablative radiation therapy (SABR) has emerged as an alternative treatment option capable of delivering a higher biologically effective dose (BED) resulting in higher local control rates in excess of 85% 2, 4, 5, 6.…”
Section: Introductionmentioning
confidence: 99%